Hong Kong Chinese population have a higher %BF for a given BMI which would partly explain why the health risks associated with obesity occur at a lower BMI. Our results would support the recommendations of using lower BMI cut-offs to define obesity in the Asia Region.
Objective: To determine whether dual-energy X-ray absorptiometry (DXA) is a valid method for body composition assessment of obese and non-obese subjects. Design: Cross-sectional study. Subjects: Chinese women living in Hong Kong; 66 of 91 subjects had body mass index (BMI) of b 25 kgam 2 . Measurements: Anthropometrics, including body weight, body height, waist and hip girth. Percentage body fat (%BF) and fat-free mass (FFM) from DXA (Hologic 2000 plus, Enhanced Array Whole Body Version 5.63) were compared with that based on a tracer dose of deuterium oxide for the determination of total body water (TBW). Results: In both obese and non-obese subjects, FFM DXA was similar to FFM TBW . The Bland and Altman-type analysis indicated that comparable between-methods differences (mean bias) and limits of agreement were obtained in obese and non-obese subjects for FFM (0.4, between 7 4.4 and 5.2 kg vs 0.5, between 7 3.1 and 4.1 kg) and %BF ( 7 0.6, between 7 7.6 and 6.4% vs 7 1.2, between 7 8.6 and 6.2%). The %BF bias was independent of age, BMI, hip circumference, and waist-to-hip ratio, but correlated with waist girth (r 0.24, P 0.021). Conclusion: The sources of bias are methodological and anthropometric in nature. The between-methods differences, however, are small and clinically insigni®cant. DXA is a valid method for assessing the body composition of obese patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.